Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic

K Yamane1

  • 1Department of Internal Medicine, University of Tsukuba.

Insights

Endothelin-1 (ET-1) is a potent vasoconstrictor linked to vascular diseases. Elevated ET-1 levels in systemic sclerosis and Raynaud

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Rheumatology

Background:

  • Endothelin-1 (ET-1) is a potent vasoconstrictor involved in vascular regulation.
  • Elevated ET-1 levels are observed in various diseases with vascular involvement and endothelial cell activation.
  • Diseases implicated include systemic sclerosis, Raynaud's phenomenon, pulmonary hypertension, Buerger's disease, and Takayasu's arteritis.

Purpose of the Study:

  • To review the clinical significance and pathogenetic role of endothelin in collagen vascular diseases.
  • To focus on the role of ET-1 in Raynaud's phenomenon and systemic sclerosis.

Main Methods:

  • Review of recent findings on endothelin in collagen vascular diseases.
  • Analysis of clinical and laboratory observations supporting vascular pathogenesis in systemic sclerosis.

Main Results:

  • Plasma ET-1 levels are elevated in patients with systemic sclerosis.
  • Higher ET-1 elevation is noted in diffuse scleroderma compared to limited scleroderma patients.
  • These findings support a vascular pathogenesis for systemic sclerosis.

Conclusions:

  • Circulating ET-1 plays a significant role in the pathogenesis of vascular and fibrotic lesions in collagen vascular diseases.
  • The elevated ET-1 levels in systemic sclerosis further support its vascular etiology.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...